Tender for Inj. Ranibizumab (Each Pfs/ Amp/Vial Contains Rani...

Purchaser's Detail

Tender's Details

Inj. Ranibizumab (Each PFS/ Amp/Vial contains Ranibizumab upto 2.3 mg/ 0.23 ml) {The drug should be DGCI approved for Diabetic Macular oedema, Retinal vein occlusion, Proliferative Diabetic Retinopathy, Retinopathy of Prematurity and Myopic Choroidal Neovascular Membrane.}
Inj. Ranibizumab (Each PFS/ Amp/Vial contains Ranibizumab upto 2.3 mg/ 0.23 ml) {The drug sho uld be DGCI approved for Diabetic Macular oedema, Retinal vein occlusion, Proliferative Diabetic Retinopathy, R etinopathy of Prematurity and Myopic Choroidal Neovascular Membrane.}
Contract Category: Expenditure
Contract Type : Goods
Tender Type : Open - Indigenous
Contract Category : Expenditure
Evaluation Criteria : Itemwise/Consigneewise
Bidding System : Single Packet
Pre-Bid Conference Required : No
Pre-Bid Conference Date Time : Not Applicable
Tendering Section : P 28
Inspection Agency : CONSIGNEE
Publishing Date / Time : 31/05/2024 15:28
Procure From Approved Sources : Yes
Approving Agency : Rly. Board
Closing Date Time : 25/06/2024 11:30
Validity of Offer ( Days) : 90
Ranking Order for Bids : Lowest to Highest
Advertised Value :
Tender Doc. Cost (INR) : 0.00
Earnest Money (INR) : 55360.00

Consignee
Divisional Rly. Hospital- BSB, NER 150.00 Numbers
Divisional Rly. Hospital- IZN, NER 20.00 Numbers
LNM Central Hospital Gorakhpur,
NER
105.00 Numbers